Stockscreener 앱 받기
2.1878
1.89%
-0.0422
시간 외 거래:
2.19
0.0022
+0.10%
전일 마감가:
$2.23
열려 있는:
$2.23
하루 거래량:
13,447
Relative Volume:
0.14
시가총액:
$27.82M
수익:
$2.47M
순이익/손실:
$-13.87M
주가수익비율:
-1.7933
EPS:
-1.22
순현금흐름:
$-12.42M
1주 성능:
-1.45%
1개월 성능:
-5.29%
6개월 성능:
-35.65%
1년 성능:
-48.50%
1일 변동 폭
$2.1404
$2.25
1주일 범위
$1.92
$2.25
52주 변동 폭
$1.31
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
CLGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.1878 | 28.36M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-17 | 개시 | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스
CLGN Analyst Rating Maintained: November 2025 Update | CLGN Stock News - GuruFocus
CollPlant Biotechnologies Reports Q3 2025 Financial Results - TipRanks
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31 - Investing.com
CollPlant Biotechnologies Announces Annual and Extraordinary General Meeting for December 2025 - TipRanks
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer) | CLGN SEC FilingForm 6-K - Stock Titan
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
CollPlant (CLGN) Sees Significant Q3 Revenue Growth and Advances in Bioprinting - GuruFocus
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention - Stocktwits
CollPlant shares edge down as Q3 revenue falls short of estimates - Investing.com Australia
CollPlant shares edge down as Q3 revenue falls short of estimates By Investing.com - Investing.com South Africa
CollPlant Biotechnologies' Q3 revenue rises on rhCollagen sales, cuts workforce - TradingView
CLGN: Revenue and net loss improved year-over-year, with expanded North American operations and new product milestones - TradingView
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
CollPlant Biotechnologies's Earnings Outlook - Benzinga
Is CollPlant Biotechnologies Ltd a good long term investmentPrice Action Trading & Free Risk Assessment and Control - earlytimes.in
What analysts say about CollPlant Biotechnologies Ltd stockFundamental Stock Analysis & Fast Profit Trading Ideas - earlytimes.in
Can CollPlant Biotechnologies Ltd. stock sustain market leadership2025 Top Decliners & Growth Focused Stock Reports - newser.com
Is CollPlant Biotechnologies Ltd. (CPT) stock resilient in recession scenariosJuly 2025 Retail & Consistent Profit Trade Alerts - newser.com
Why CollPlant Biotechnologies Ltd. stock is rated strong buy2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
How CollPlant Biotechnologies Ltd. stock trades during market volatility2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Is CollPlant Biotechnologies Ltd. stock trading at a premium valuation2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Why CollPlant Biotechnologies Ltd. (CPT) stock could be top winner2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Is CollPlant Biotechnologies Ltd. forming a bottoming baseJuly 2025 Retail & Verified Momentum Watchlists - newser.com
How analysts rate CollPlant Biotechnologies Ltd. stock today2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
When is the best time to exit CollPlant Biotechnologies Ltd.Weekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com
How to forecast CollPlant Biotechnologies Ltd. trends using time seriesQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com
CollPlant Biotechnologies (CLGN) to Release Earnings on Wednesday - Defense World
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS - MarketScreener
CollPlant Biotechnologies (NASDAQ: CLGN) to report third quarter 2025 results Nov. 26 - Stock Titan
How CollPlant Biotechnologies Ltd. stock benefits from tech adoptionMarket Trend Summary & Risk Managed Investment Signals - newser.com
Will CollPlant Biotechnologies Ltd. (CPT) stock benefit from commodity supercycle2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Will CollPlant Biotechnologies Ltd. stock go up soonJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
What Wall Street predicts for CollPlant Biotechnologies Ltd. stock priceQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Collplant Biotechnologies Ltd (CLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.13%
자본화:
|
볼륨(24시간):